Compare NOV & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOV | BLCO |
|---|---|---|
| Founded | 1862 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.0B |
| IPO Year | 1996 | 2022 |
| Metric | NOV | BLCO |
|---|---|---|
| Price | $17.94 | $17.28 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 14 | 14 |
| Target Price | $16.71 | ★ $17.31 |
| AVG Volume (30 Days) | ★ 3.9M | 332.5K |
| Earning Date | 02-04-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $8,775,000,000.00 | $4,976,000,000.00 |
| Revenue This Year | N/A | $8.06 |
| Revenue Next Year | N/A | $5.79 |
| P/E Ratio | $18.06 | ★ N/A |
| Revenue Growth | N/A | ★ 6.23 |
| 52 Week Low | $10.84 | $10.45 |
| 52 Week High | $18.22 | $18.14 |
| Indicator | NOV | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 66.43 | 56.07 |
| Support Level | $17.55 | $17.18 |
| Resistance Level | $18.22 | $17.86 |
| Average True Range (ATR) | 0.55 | 0.42 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 89.87 | 64.63 |
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.